Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent <i>In Vivo</i> Activities in Mouse Models of Hematological and Solid Tumors
James C. Tarr(Vanderbilt University), Stephen W. Fesik(Vanderbilt University)
Cited by 16
Related Papers
ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
|Cancer Research|2008|2k
Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer
|Journal of Medicinal Chemistry|2004|364
Influence of Bcl-2 Family Members on the Cellular Response of Small-Cell Lung Cancer Cell Lines to ABT-737
|Cancer Research|2007|302
Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL
|Journal of Medicinal Chemistry|2007|295